Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Revenue
0
0
0
0
Revenue Growth (YoY)
--
--
--
--
Cost of Revenue
0
0
--
--
Gross Profit
0
0
--
--
Selling, General & Admin
1
1
0
0
Research & Development
--
--
--
0
Operating Expenses
1
1
0
0
Other Non Operating Income (Expenses)
--
--
--
--
Pretax Income
-1
-1
0
0
Income Tax Expense
--
--
0
0
Net Income
-1
-1
0
0
Net Income Growth
--
--
--
--
Shares Outstanding (Diluted)
112.03
57.05
5.15
5.15
Shares Change (YoY)
--
1,007%
0%
--
EPS (Diluted)
-0.01
-0.02
-0.02
-0.02
EPS Growth
--
-14%
38%
--
Free Cash Flow
0
0
0
0
Free Cash Flow Per Share
--
--
--
--
Gross Margin
0%
0%
--
--
Operating Margin
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
Free Cash Flow Margin
0%
0%
0%
0%
EBITDA
-1
-1
--
--
EBITDA Margin
0%
0%
--
--
D&A For EBITDA
0
0
--
--
EBIT
-1
-1
0
0
EBIT Margin
0%
0%
0%
0%
Effective Tax Rate
--
--
0%
0%
Follow-Up Questions
What are Manuka Inc's key financial statements?
What are the key financial ratios for MNKA?
How is Manuka Inc's revenue broken down by segment or geography?
Is Manuka Inc profitable?
Does Manuka Inc have any liabilities?
How many outstanding shares for Manuka Inc?
Key Stats
Prev.Close
$0.0001
Open
$0.0001
Day's Range
$0.0001 - $0.0001
52 week range
$0.0001 - $0.0021
Volume
100
Avg.Volume
0
EPS (TTM)
-0.01
Dividend yield
--
Market Cap
$11.2K
What is MNKA?
Manuka, Inc. is a biopharmaceutical company. The Company’s products include Face Serum with Manuka Honey and Bee Venom, Face Serum with Enhanced Vitamin C, Day Cream, Nourishing Night Cream with Manuka Honey and Nee Venom, Eye Cream with Manuka Honey and Bee Venom, Face Cleanser Gel and Face Serum. Its Face Serum with Manuka Honey and Bee Venom supports blurring and reduces skin wrinkles. The company regenerates skin cells and gives a young and vital appearance to the skin. The bee venom encourages natural skin revival, boosts production of Collagen, enhances skin elasticity and has healing properties for damages skin cells.